Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Myeloid 2Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 9Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Myelodysplastic Syndromes 6Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3Hematologic Neoplasms 3Myeloproliferative Disorders 2Lymphoma, Non-Hodgkin 2Leukemia, Biphenotypic, Acute 2Hodgkin Disease 2Graft vs Host Disease 2Ganglioneuroblastoma 2Blastic Plasmacytoid Dendritic Cell Neoplasm 2Teratoma 1Recurrence 1Neuroblastoma 1Multiple Myeloma 1Medulloblastoma 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma 1Leukemia, Myelomonocytic, Juvenile 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Accelerated Phase 1Leukemia, Myeloid 1Leukemia, Mast-Cell 1Leukemia, Large Granular Lymphocytic 1Leukemia 1High Risk Myeloid Malignancies 1GATA2 Deficiency 1Choriocarcinoma 1Carcinoma, Embryonal 1

Interventions

ruxolitinib 9fludarabine phosphate 8fludarabine 8Whole-Body Irradiation 8Specimen Handling 7Cytarabine 7Cyclophosphamide 7Mycophenolic Acid 6Tacrolimus 5Injections 5Busulfan 5Biopsy 5Azacitidine 5Stem Cell Transplantation 4Sirolimus 4Peripheral Blood Stem Cell Transplantation 4Melphalan 4Granulocyte Colony-Stimulating Factor 4CPX-351 4venetoclax 3luspatercept 3decitabine and cedazuridine drug combination 3Liposomes 3Idarubicin 3Daunorubicin 3Cyclosporine 3Blood Specimen Collection 311-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 3selinexor 2nilotinib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Myeloproliferative Disorders × Thiotepa × 90 days × Clear all
NCT03779854 2026-05-14

Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant

Fred Hutchinson Cancer Center

Phase 2 Recruiting
68 enrolled
LymphoidMyeloidOther hematologic neoplasm

GATA2 Deficiency, Blastic Plasmacytoid Dendritic Cell Neoplasm, Burkitt Lymphoma, Leukemia, Mast-Cell, Leukemia, Myeloid, Myeloproliferative Disorders, Leukemia, Biphenotypic, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05088356 2026-05-12

Reduced Intensity Allogeneic HCT in Advanced Hematologic Malignancies w/T-Cell Depleted Graft

Stanford University

Phase 1 Active not recruiting
66 enrolled
MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡